Portfolio of Renaissance Technologies
Renaissance Technologies was founded by Jim Simons († 2024) and makes investment decisions with mathematical models; the portfolio holds a very large number of stocks.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 13, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2024. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 66.5B USD
- Positions
- 3,484
- Share of the ten largest
- 11.1%
The ten largest positions Q3 2024
- Palantir Technologies 2.1%▼ −2.8%
- Novo Nordisk (ADR) 1.5%▼ −10.6%
- United Therapeutics Corp Del 1.2%▼ −0.9%
- Apple Inc. 1.1%▲ +90.3%
- Vertex Pharmaceuticals 1.1%▲ +4.2%
- Microsoft 1.0%▲ +383.6%
- Verisign 0.9%▲ +4.9%
- Sprouts Fmrs Mkt Inc 0.7%▲ +0.1%
- Airbnb 0.7%▲ +6.3%
- Nvidia 0.6%▼ −49.8%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q3 2024
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| PLTR Palantir Technologies | 2.1% | 38,419,240 | 1.4B USD | −2.8% reduced | Q2 2021 14 quarters |
| NVO Novo Nordisk (ADR) | 1.5% | 8,189,315 | 975.1M USD | −10.6% reduced | Q2 2013 or earlier 46 quarters |
| United Therapeutics Corp Del | 1.2% | 2,155,392 | 772.4M USD | −0.9% reduced | Q2 2013 or earlier 46 quarters |
| AAPL Apple Inc. | 1.1% | 3,276,203 | 763.4M USD | +90.3% increased | Q3 2020 17 quarters |
| VRTX Vertex Pharmaceuticals | 1.1% | 1,631,493 | 758.8M USD | +4.2% increased | Q1 2017 31 quarters |
| MSFT Microsoft | 1.0% | 1,571,271 | 676.1M USD | +383.6% increased | Q2 2024 2 quarters |
| VRSN Verisign | 0.9% | 3,175,990 | 603.3M USD | +4.9% increased | Q2 2013 or earlier 46 quarters |
| Sprouts Fmrs Mkt Inc | 0.7% | 4,440,644 | 490.3M USD | +0.1% increased | Q2 2016 34 quarters |
| ABNB Airbnb | 0.7% | 3,616,495 | 458.6M USD | +6.3% increased | Q2 2021 14 quarters |
| NVDA Nvidia | 0.6% | 3,528,071 | 428.4M USD | −49.8% reduced | Q1 2023 7 quarters |
| Exelixis Inc | 0.6% | 15,359,916 | 398.6M USD | +1.3% increased | Q3 2016 33 quarters |
| Franco Nev Corp | 0.6% | 3,138,549 | 390.0M USD | +2.1% increased | Q1 2014 43 quarters |
| Cboe Global Mkts Inc | 0.6% | 1,879,724 | 385.1M USD | +0.3% increased | Q2 2013 or earlier 46 quarters |
| FTNT Fortinet | 0.6% | 4,943,162 | 383.3M USD | −1.7% reduced | Q3 2015 37 quarters |
| META Meta Platforms | 0.6% | 647,424 | 370.6M USD | −38.1% reduced | Q3 2021 13 quarters |
| GILD Gilead Sciences | 0.5% | 4,188,524 | 351.2M USD | −17.2% reduced | Q4 2014 40 quarters |
| Allison Transmission HLDGS I | 0.5% | 3,423,419 | 328.9M USD | −2.8% reduced | Q3 2013 45 quarters |
| Monday Com Ltd | 0.5% | 1,138,290 | 316.2M USD | +1.4% increased | Q4 2021 12 quarters |
| DASH DoorDash | 0.5% | 2,186,688 | 312.1M USD | −21.6% reduced | Q2 2021 14 quarters |
| CME CME Group | 0.5% | 1,403,089 | 309.6M USD | +126.8% increased | Q3 2021 13 quarters |
| Corcept Therapeutics Inc | 0.5% | 6,509,002 | 301.2M USD | −5.8% reduced | Q1 2015 39 quarters |
| NFLX Netflix | 0.4% | 420,209 | 298.0M USD | +54.7% increased | Q2 2024 2 quarters |
| INCY Incyte | 0.4% | 4,499,540 | 297.4M USD | −13.8% reduced | Q4 2017 28 quarters |
| Neurocrine Biosciences Inc | 0.4% | 2,574,546 | 296.6M USD | +4.3% increased | Q4 2018 24 quarters |
| Wingstop Inc | 0.4% | 699,146 | 290.9M USD | +15.9% increased | Q1 2023 7 quarters |
| Commvault Sys Inc | 0.4% | 1,884,285 | 289.9M USD | +3.9% increased | Q2 2013 or earlier 46 quarters |
| Etsy Inc | 0.4% | 5,186,091 | 288.0M USD | +23.0% increased | Q1 2023 7 quarters |
| CCL Carnival Corporation | 0.4% | 15,376,905 | 284.2M USD | +60.4% increased | Q2 2023 6 quarters |
| Kinross Gold Corp | 0.4% | 29,637,775 | 277.4M USD | +2.7% increased | Q2 2013 or earlier 46 quarters |
| Zoom Video Communications In | 0.4% | 3,923,948 | 273.7M USD | +13.5% increased | Q1 2020 19 quarters |
| New Oriental Ed & Technology | 0.4% | 3,586,654 | 272.0M USD | +12.9% increased | Q2 2022 10 quarters |
| Dropbox Inc | 0.4% | 10,628,263 | 270.3M USD | +3.0% increased | Q1 2019 23 quarters |
| MU Micron Technology | 0.4% | 2,604,914 | 270.2M USD | new | Q3 2024 1 quarter |
| RBLX Roblox | 0.4% | 6,092,538 | 269.7M USD | +41.6% increased | Q2 2021 14 quarters |
| Novartis AG | 0.4% | 2,300,678 | 264.6M USD | −8.0% reduced | Q3 2013 45 quarters |
| Docusign Inc | 0.4% | 4,157,988 | 258.2M USD | +11.5% increased | Q3 2019 21 quarters |
| Spotify Technology S A | 0.4% | 680,006 | 250.6M USD | +15.9% increased | Q1 2022 11 quarters |
| Nutanix Inc | 0.4% | 4,150,500 | 245.9M USD | +11.0% increased | Q1 2021 15 quarters |
| TEAM Atlassian | 0.4% | 1,520,723 | 241.5M USD | −0.1% reduced | Q2 2016 34 quarters |
| KR Kroger | 0.3% | 4,051,770 | 232.2M USD | −20.4% reduced | Q2 2019 22 quarters |
| Hologic Inc | 0.3% | 2,818,190 | 229.6M USD | +10.8% increased | Q3 2020 17 quarters |
| Molina Healthcare Inc | 0.3% | 662,987 | 228.4M USD | −30.2% reduced | Q2 2013 or earlier 46 quarters |
| LLY Lilly (Eli) | 0.3% | 257,813 | 228.4M USD | new | Q3 2024 1 quarter |
| ABBV AbbVie | 0.3% | 1,137,571 | 224.6M USD | −12.8% reduced | Q1 2018 27 quarters |
| Cava Group Inc | 0.3% | 1,803,015 | 223.3M USD | +102.0% increased | Q1 2024 3 quarters |
| REGN Regeneron Pharmaceuticals | 0.3% | 211,423 | 222.3M USD | +14.2% increased | Q3 2021 13 quarters |
| LMT Lockheed Martin | 0.3% | 373,200 | 218.2M USD | +150.0% increased | Q4 2022 8 quarters |
| Dicks Sporting Goods Inc | 0.3% | 1,042,740 | 217.6M USD | −5.7% reduced | Q3 2020 17 quarters |
| National Grid PLC | 0.3% | 3,119,585 | 217.3M USD | +1.8% increased | Q2 2017 30 quarters |
| Corvel Corp | 0.3% | 654,219 | 213.9M USD | −2.2% reduced | Q2 2013 or earlier 46 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 3,484 positions.
Breakdown by sector
- Technology 10.2%
- Health Care 6.0%
- Industrials 5.3%
- Consumer Discretionary 5.2%
- Financials 3.5%
- Consumer Staples 2.3%
- Communication Services 2.1%
- Energy 1.3%
- Real Estate 0.9%
- Utilities 0.8%
- Materials 0.6%
- not in our coverage 61.9%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors